Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India

AIDS Research and Human Retroviruses

Volumn 25, Issue 2, 2009, Pages 217-224

  Suhadev, Mohanarani ^a   Nyamathi, Adeline M ^b   Swaminathan, Soumya ^a   Suresh, Anitha ^a   Venkatesan, P ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CONDOM; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MARRIED WOMAN; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; REFUSAL TO PARTICIPATE; SEXUAL BEHAVIOR;

ADULT; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 60849107777     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0312     Document Type: Article

References (28)

1. Sushma K and Jean LE: Preparing for AIDS vaccine research. Sankalp 2006;5(4).
2. Newman PA, Duan N, Lee SJ, Reedy E, Saiden D, Kakinami L, and Cunnigham W: Willingness to participate in HIV vaccine trials: The impact of trial attributes. Prev Med 2007;44(6):554-557.
3. Ministry of Health, Dar es Salaam, the United Republic of Tanzania: National HIV Vaccine Strategic Framework, 2005.
4. Nyamathi AM, Suhadev M, Swaminathan S, et al.: Perceptions of a community sample about participation in future HIV vaccine trials in South India. AIDS Behav 2006;1(4):619-627.
5. National AIDS Control Organisation (NACO), Ministry of Health & Family Welfare, Government of India, New Delhi, India: HIV/AIDS, epidemiological surveillance and estimation report for the year 2006.
6. Chandrasekaran P, Dattabetta G, Loo V, Rao S, Goyle H, and Alexander A: Containing HIV/AIDS in India: The unfinished agenda. Lancet Infect Dis 2006;6:508-521.
7. Koblin BA, Avrett S, Taylor PE, et al.: Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City-Project. ACHIEVE. J Acquire Immune Defic Syndr Hum Retrovirol 1997;15:165-171.
8. Bartholow BN, Mac Queen KM, Douglas JM Jr, et al.: Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquire Immune Defic Syndr Hum Retrovirol 1997;16:108-115.
9. Sherbourne CD and Stewart AL: The MOS social support survey. Soc Sci Med 1991;32(6):705-714.
10. Kiwanuka N, Robb M, Kigozi G, et al.: Knowledge about vaccines and willingness to participate in prevention HIV vaccine trials. Acquire Immune Defic Syndr 2004;36:2721-2725.
11. Koblin BA, Holte S, Lenderking B, et al.: Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV Network for Prevention Trials. J Acquir Immune Defic Syndr 2000;24:451-457.
12. Lisau A and Zimet GD: Undergraduates' perception of HIV immunization: Attitudes and behaviours as determining factors. Int J STD AIDS 2000;11:445-450.
13. MacQueen KM, Vanichseni S, Kitayaporn D, et al.: Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999;21:243-251.
14. Hays RB and Kegeles SM: Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:164-171.
15. McGrath JW, George K, Svilar G, et al.: Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr 2001;27:381-388.
16. Newman PA, Naihu D, Rudy ET, et al.: Challenges for HIV vaccine discrimination and clinical trial recruitment: If we build it, will they come? AIDS Patient Care STDs 2007;8(12):691-701.
17. Hammer SM and Corey L: What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: Issues involving surrogate end points in Phase 3 trials. J Infect Dis 2003;188:179-193.
18. Anderson RM and Garnett GP: Low-efficacy HIV vaccines: Potential for community-based intervention programmes. Lancet 1996;348:1010-1013.
19. Blower SM and McLean AR: Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science 1994;265:1451-1454.
20. Blower S, Schwartz EJ, and Mills J: Forecasting the future of HIV epidemics: The impact of antiretroviral therapies and imperfect vaccines. AIDS Rev 2003;5:113-125.
21. Sahay S, Mehendale S, Sam S, et al.: Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine 2005;23:1351-1358.
22. Future access to HIV vaccines: Report from a WHO-UNAIDS Consultation, Geneva, Switzerland, 2-3 October 2000. AIDS 2001;5(7):W27-W44.
23. Celantano DD, Beyner C, Navrpratan C, et al.: Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS 1995;9:1079-1083.
24. Steinbrook R: Perspective: HIV in India - a complex epidemic. N Engl J Med 2007;356(11):1089-1093.
25. Chesney MA, Chambers DB, and Kahn JO: Risk behaviour for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:266-271.
26. Bartholow BN, Buchbinder S, Goli V, et al.: HIV risk behaviour change over 24 months of follow-up in a phase-III HIV vaccine efficacy trial. Paper presented at the AIDS Conference 2002, Barcelona, Spain, July 7-12, 2002.
27. Bartholow B, Buchbinder S, and McKirnan D: HIV risk behaviour change in phase III HIV vaccine efficacy trial. Paper presented at AIDS Vaccine 2001, Philadelphia, PA, September 5-8, 2001.
28. Suhadev M, Nyamathi AM, Swaminathan S, et al.: A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res 2006;124:631-640.